VIBRAMYCIN CAP 100MG 100 MG — DIN 00024368
DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG · PFIZER CANADA ULC · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is VIBRAMYCIN CAP 100MG?
VIBRAMYCIN CAP 100MG 100 MG contains DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00024368, held by PFIZER CANADA ULC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Apr-2016. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is VIBRAMYCIN CAP 100MG used for?
Treatment of pneumonia, respiratory tract infections, genitourinary tract infections (including Chlamydia), skin/soft tissue infections, and gastro-intestinal infections due to susceptible organisms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Doxycycline cost around the world?
Doxycycline is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Australia | ex-manufacturer | 9 | 64 | AUD███.██ |
| Saudi Arabia | public | 13 | 16 | SAR███.██ |
| Morocco | PPV (public price) | 8 | 14 | MAD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 8 | 13 | EUR███.██ |
| South Africa | single exit price | 9 | 13 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 4 | 6 | CZK███.██ |
| United States | acquisition | 2 | 6 | USD███.██ |
| Bahrain | retail (max) | 3 | 5 | BHD███.██ |
| United Kingdom | hospital | 5 | 5 | GBP███.██ |
| Luxembourg | reimbursement | 4 | 4 | EUR███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
150 pack listings across 69 brand entries and 12 price bases, refreshed 08 Sep 2026. Ranges span every Doxycycline pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Doxycycline in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Doxycycline, across 43 DINs, of which 14 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 4 | 3 | APO-DOXY CAP 100MG, APO-DOXY TABS 100MG, APO-DOXYCYCLINE MODIFIED RELEASE, APO-DOXYCYCLINE MR | Sourceable in Canada |
| TEVA CANADA LIMITED | 4 | 2 | NTP-DOXYCYCLINE CAPSULES, NTP-DOXYCYCLINE TABLETS, TEVA-DOXYCYCLINE | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | JAMP DOXYCYCLINE CAPSULES, JAMP DOXYCYCLINE TABLETS | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 2 | 1 | DOXYCIN CAP 100MG, DOXYCIN TAB 100MG | Sourceable in Canada |
| PRO DOC LIMITEE | 2 | 1 | DOXYCYCLINE-100 CAP 100MG USP, DOXYTAB | Sourceable in Canada |
| ANGITA PHARMA INC. | 1 | 1 | AG-DOXYCYCLINE | Sourceable in Canada |
| GALDERMA CANADA INC | 1 | 1 | APPRILON | Sourceable in Canada |
| MANTRA PHARMA INC | 1 | 1 | M-DOXYCYCLINE | Sourceable in Canada |
| NORA PHARMA INC | 1 | 1 | NRA-DOXYCYCLINE | Sourceable in Canada |
| PHARMARIS CANADA INC | 1 | 1 | PRZ-DOXYCYCLINE | Sourceable in Canada |
| RHODIAPHARM INC | 4 | 0 | RHO-DOXYCIN - CAP 100MG, RHO-DOXYCIN TABS - 100MG, RHO-DOXYCYCLINE - CAP 100MG, RHO-DOXYCYCLINE - TAB 100MG | No marketed DIN |
| PFIZER CANADA ULC | 3 | 0 | VIBRA-TABS, VIBRAMYCIN CAP 100MG, VIBRAMYCIN INJ | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
| Pack configuration (monograph) | Vibramycin Capsules: Bottles of 50. Vibra-Tabs: Bottles of 100. |
| Storage | Store at 15-30°C; protect from light. Dispense in a light-resistant container. |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Doxycycline |
|---|---|
| ATC code | J01AA02 |
| AHFS class | 08:12.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00024368 |
|---|---|
| DIN (unpadded, as printed on some documents) | 24368 |
| Brand name | VIBRAMYCIN CAP 100MG |
| Generic / active ingredient | DOXYCYCLINE (DOXYCYCLINE HYCLATE) : 100 MG |
| Market authorization holder | PFIZER CANADA ULC |
| Health Canada schedule | Prescription |
| ATC code | J01AA02 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01AA |
| Current status | CANCELLED POST MARKET |
| Status date | 04-Apr-2016 |
| Original market date | 1969-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 200 mg loading dose on day 1, then 100 mg daily. Severe infections: 200 mg daily. Take with a full glass of water while upright; do not take at bedtime.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to doxycycline or tetracyclines; myasthenia gravis; concurrent use with isotretinoin.
Warnings and precautions
Risk of permanent tooth discoloration in children <8 and during pregnancy/lactation. Esophageal injury risk. Clostridium difficile-associated disease (CDAD). Photosensitivity.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
14 of 43 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-DOXYCYCLINE | 100 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02556928 |
| APO-DOXY CAP 100MG | 100 MG | CAPSULE | APOTEX INC | MARKETED | 00740713 |
| APO-DOXY TABS 100MG | 100 MG | TABLET | APOTEX INC | MARKETED | 00874256 |
| APO-DOXYCYCLINE MR | 40 MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | APOTEX INC | MARKETED | 02512645 |
| APPRILON | 40 MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | GALDERMA CANADA INC | MARKETED | 02375885 |
| DOXYCIN TAB 100MG | 100 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | 00860751 |
| DOXYTAB | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | 00887064 |
| JAMP DOXYCYCLINE CAPSULES | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02528940 |
| JAMP DOXYCYCLINE TABLETS | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02554372 |
| M-DOXYCYCLINE | 100 MG | TABLET | MANTRA PHARMA INC | MARKETED | 02543478 |
2 · Same class — other molecules in ATC J01AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Doxycycline | AG-DOXYCYCLINE · ALTI-DOXYCYCLINE - TAB 100MG · ALTI-DOXYCYCLINE-CAP 100MG · APO-DOXY CAP 100MG · +34 more | 43 | 14 | Yes |
| Minocycline | AVA-MINOCYCLINE · DOM-MINOCYCLINE CAPSULES · ENCA 100MG · ENCA 50MG · +16 more | 36 | 2 | Yes |
| Tigecycline | TIGECYCLINE · TIGECYCLINE FOR INJECTION · TYGACIL | 3 | 2 | Yes |
| Tetracycline | ACHROMYCIN V CAP 250MG · APO TETRA TABS 250MG · JAA TETRA TAB 250MG · MEDICYCLINE CAP 250MG · +6 more | 12 | 1 | Yes |
| Demeclocycline | DECLOMYCIN · DECLOMYCIN - TAB 300MG · DECLOMYCIN TAB 150MG · DECLOMYCIN TAB 300MG | 4 | 0 | Not in Canada |
| Rolitetracycline | REVERIN 275MG | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is VIBRAMYCIN CAP 100MG called?
The same molecule, Doxycycline, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| APX-Doxycycline | Latin | Australia |
| Doxsig | Latin | Australia |
| Doxycycline Sandoz | Latin | Australia |
| DOXYCYCLINE-WGR | Latin | Australia |
| Mayne Pharma Doxycycline | Latin | Australia |
| Doryx | Latin | Australia |
| Blooms The Chemist Doxycycline | Latin | Australia |
| Doxydar | Latin | Bahrain, Saudi Arabia |
| DOXYHEXAL | Latin | Czechia |
| DOXYMYCINE | Latin | Morocco |
| Cyclidox Capsules | Latin | South Africa |
| DOXINE | Latin | Morocco |
| Doxymed | Latin | South Africa |
| FARMODOXI | Latin | Morocco |
| ISTACYNE | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.